P01.111 Using the ASCO and ESMO frameworks to assess the clinical value of tumor treating fields for newly diagnosed Glioblastoma multiforme

Por Proescholdt, C, Kelly, J, Kinzel, A, Bähr, O
Publicado no Neuro Oncol (2018)

Genomic profiling in non-small-cell lung cancer in young patients. A systematic review

Por Viñal, D., Martínez, D., Higuera, O., de Castro, J.
Publicado no ESMO Open (2021)

Comparison of guidelines for the management of rectal cancer

Por Luzietti, E., Pellino, G., Nikolaou, S., Qiu, S., Mills, S., Warren, O., Tekkis, P., Kontovounisios, C.
Publicado no BJS Open (2018)

High body mass index and pre-existing autoimmune disease are associated with an increased risk of immune-related adverse events in cancer patients treated with PD-(L)1 inhibitors a...

Por Gülave, B., Hew, M.N., de Groot, J.S., Rodwell, L., Teerenstra, S., Fabriek, B.O.
Publicado no ESMO Open (2021)

Erratum to ‘Longitudinal characterisation of haematological and biochemical parameters in cancer patients prior to and during COVID-19 reveals features associated with outcome’: [ESMO Open Volume 6, Issue...

Por Lee, R.J., Wysocki, O., Bhogal, T., Shotton, R., Tivey, A., Angelakas, A., Aung, T., Banfill, K., Baxter, M., Boyce, H., Brearton, G., Copson, E., Dickens, E., Eastlake, L., Gomes, F., Hague, C., Harrison, M., Horsley, L., Huddar, P., Hudson, Z., Khan, S., Khan, U.T., Maynard, A., McKenzie, H., Palmer, D., Robinson, T., Rowe, M., Thomas, A., Tweedy, J., Sheehan, R., Stockdale, A., Weaver, J., Williams, S., Wilson, C., Zhou, C., Dive, C., Cooksley, T., Palmieri, C., Freitas, A., Armstrong, A.C.
Publicado no ESMO Open (2021)

The impact of COVID-19 on oncology professionals: results of the ESMO Resilience Task Force survey collaboration

Por Banerjee, S., Lim, K.H.J., Murali, K., Kamposioras, K., Punie, K., Oing, C., O'Connor, M., Thorne, E., Devnani, B., Lambertini, M., Westphalen, C.B., Garrido, P., Amaral, T., Morgan, G., Haanen, J.B.A.G., Hardy, C.
Publicado no ESMO Open (2021)

PHOTOSTENT-02: porfimer sodium photodynamic therapy plus stenting versus stenting alone in patients with locally advanced or metastatic biliary tract cancer

Por Pereira, Stephen P, Jitlal, Mark, Duggan, Marian, Lawrie, Emma, Beare, Sandy, O’Donoghue, Pam, Wasan, Harpreet S, Valle, Juan W, Bridgewater, John
Publicado no ESMO Open (2018)

Adolescents and young adults (AYA) with cancer: a position paper from the AYA Working Group of the European Society for Medical Oncology (ESMO) and the European Society for Paediatric Oncology (SIOPE)

Por Ferrari, A., Stark, D., Peccatori, F.A., Fern, L., Laurence, V., Gaspar, N., Bozovic-Spasojevic, I., Smith, O., De Munter, J., Derwich, K., Hjorth, L., van der Graaf, W.T.A., Soanes, L., Jezdic, S., Blondeel, A., Bielack, S., Douillard, J.-Y., Mountzios, G., Saloustros, E.
Publicado no ESMO Open (2021)

Indolent peritoneal mesothelioma: PI3K-mTOR inhibitors as a novel therapeutic strategy

Por Dolly, Saoirse O, Migali, Cristina, Tunariu, Nina, Della-Pepa, Chiara, Khakoo, Shelize, Hazell, Steve, de Bono, Johann S, Kaye, Stanley B, Banerjee, Susana
Publicado no ESMO Open (2017)

Interventions to improve care coordination between primary healthcare and oncology care providers: a systematic review

Por Tomasone, Jennifer R, Brouwers, Melissa C, Vukmirovic, Marija, Grunfeld, Eva, O'Brien, Mary Ann, Urquhart, Robin, Walker, Melanie, Webster, Fiona, Fitch, Margaret
Publicado no ESMO Open (2016)

An analysis of health-related quality of life in the phase III PROSELICA and FIRSTANA studies assessing cabazitaxel in patients with metastatic castration-resistant prostate cancer

Por Thiery-Vuillemin, A., Fizazi, K., Sartor, O., Oudard, S., Bury, D., Thangavelu, K., Ozatilgan, A., Poole, E.M., Eisenberger, M., de Bono, J.
Publicado no ESMO Open (2021)

Tumour and cellular distribution of activated forms of PR in breast cancers: a novel immunohistochemical analysis of a large clinical cohort

Por Bonneterre, Jacques, Bosq, Jacques, Jamme, Philippe, Valent, Alexander, Gilles, Erard M, Zukiwski, Alexander A, Fuqua, Suzanne A W, Lange, Carol A, O'Shaughnessy, Joyce
Publicado no ESMO Open (2016)

ESO-ESMO 2nd international consensus guidelines for advanced breast cancer (ABC2)(†)

Por Cardoso, F., Costa, A., Norton, L., Senkus, E., Aapro, M., André, F., Barrios, C. H., Bergh, J., Biganzoli, L., Blackwell, K. L., Cardoso, M. J., Cufer, T., El Saghir, N., Fallowfield, L., Fenech, D., Francis, P., Gelmon, K., Giordano, S. H., Gligorov, J., Goldhirsch, A., Harbeck, N., Houssami, N., Hudis, C., Kaufman, B., Krop, I., Kyriakides, S., Lin, U. N., Mayer, M., Merjaver, S. D., Nordström, E. B., Pagani, O., Partridge, A., Penault-Llorca, F., Piccart, M. J., Rugo, H., Sledge, G., Thomssen, C., van't Veer, L., Vorobiof, D., Vrieling, C., West, N., Xu, B., Winer, E.
Publicado em 2014

3rd ESO–ESMO International Consensus Guidelines for Advanced Breast Cancer (ABC 3)

Por Cardoso, F., Costa, A., Senkus, E., Aapro, M., André, F., Barrios, C. H., Bergh, J., Bhattacharyya, G., Biganzoli, L., Cardoso, M. J., Carey, L., Corneliussen-James, D., Curigliano, G., Dieras, V., El Saghir, N., Eniu, A., Fallowfield, L., Fenech, D., Francis, P., Gelmon, K., Gennari, A., Harbeck, N., Hudis, C., Kaufman, B., Krop, I., Mayer, M., Meijer, H., Mertz, S., Ohno, S., Pagani, O., Papadopoulos, E., Peccatori, F., Penault-Llorca, F., Piccart, M. J., Pierga, J. Y., Rugo, H., Shockney, L., Sledge, G., Swain, S., Thomssen, C., Tutt, A., Vorobiof, D., Xu, B., Norton, L., Winer, E.
Publicado no Ann Oncol (2017)

3rd ESO–ESMO International Consensus Guidelines for Advanced Breast Cancer (ABC 3)

Por Cardoso, F, Costa, A, Senkus, E, Aapro, M, André, F, Barrios, C H, Bergh, J, Bhattacharyya, G, Biganzoli, L, Cardoso, M J, Carey, L, Corneliussen-James, D, Curigliano, G, Dieras, V, El Saghir, N, Eniu, A, Fallowfield, L, Fenech, D, Francis, P, Gelmon, K, Gennari, A, Harbeck, N, Hudis, C, Kaufman, B, Krop, I, Mayer, M, Meijer, H, Mertz, S, Ohno, S, Pagani, O, Papadopoulos, E, Peccatori, F, Penault-Llorca, F, Piccart, M J, Pierga, J Y, Rugo, H, Shockney, L, Sledge, G, Swain, S, Thomssen, C, Tutt, A, Vorobiof, D, Xu, B, Norton, L, Winer, E
Publicado no Ann Oncol (2017)

Circulating miR-30b-5p levels in plasma as a novel potential biomarker for early detection of breast cancer

Por Adam-Artigues, A., Garrido-Cano, I., Simón, S., Ortega, B., Moragón, S., Lameirinhas, A., Constâncio, V., Salta, S., Burgués, O., Bermejo, B., Henrique, R., Lluch, A., Jerónimo, C., Eroles, P., Cejalvo, J.M.
Publicado no ESMO Open (2021)

Key differences between 13 KRAS mutation detection technologies and their relevance for clinical practice

Por Sherwood, James L, Brown, Helen, Rettino, Alessandro, Schreieck, Amelie, Clark, Graeme, Claes, Bart, Agrawal, Bhuwnesh, Chaston, Ria, Kong, Benjamin S G, Choppa, Paul, Nygren, Anders O H, Deras, Ina L, Kohlmann, Alexander
Publicado no ESMO Open (2017)

Rethinking prognostic factors in locally advanced or metastatic urothelial carcinoma in the immune checkpoint blockade era: a multicenter retrospective study

Por Ruiz-Bañobre, J., Molina-Díaz, A., Fernández-Calvo, O., Fernández-Núñez, N., Medina-Colmenero, A., Santomé, L., Lázaro-Quintela, M., Mateos-González, M., García-Cid, N., López-López, R., Vázquez, S., Anido-Herranz, U.
Publicado no ESMO Open (2021)

A randomized phase IIa study of quantified bone scan response in patients with metastatic castration-resistant prostate cancer (mCRPC) treated with radium-223 dichloride alone or i...

Por Petrylak, D.P., Vaishampayan, U.N., Patel, K.R., Higano, C.S., Albany, C., Dawson, N.A., Mehlhaff, B.A., Quinn, D.I., Nordquist, L.T., Wagner, V.J., Siegel, J., Trandafir, L., Sartor, O.
Publicado no ESMO Open (2021)

Awareness of predatory journals and open access among medical oncologists: results of an online survey

Por Richtig, Georg, Richtig, Erika, Böhm, Alexandra, Oing, Christoph, Bozorgmehr, Farastuk, Kruger, Stephan, Kiesewetter, Barbara, Zielinski, Christoph, Berghoff, Anna S
Publicado no ESMO Open (2019)